Allen Nissenson - May 19, 2022 Form 4 Insider Report for Angion Biomedica Corp. (ELTX)

Role: Director
Signature: /s/ Jennifer J. Rhodes, as attorney-in fact for Allen Nissenson
Stock symbol: ELTX
Transactions as of: May 19, 2022
Transactions value $: $10,925
Form type: 4
Date filed: 5/23/2022, 07:48 PM
Previous filing: Jun 22, 2021
Next filing: Jun 9, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELTX	Common Stock	Purchase	$8.52K	+7.35K		$1.16^*	7.35K	May 19, 2022	Direct	F1
transaction	ELTX	Common Stock	Purchase	$2.4K	+2.04K	+27.73%	$1.18^*	9.38K	May 20, 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.14 to $1.18 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.14 to $1.18 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.